Discussions marquées : HIB

IVAC VIMS Report on Global Vaccine Introduction - September 2015 Now Available!

Thuy-Linh Nguyen Publié dans :
The September 2015 Vaccine Information Management System (VIMS)Report on Global Vaccine Introductionfrom IVAC at Johns Hopkins is now availablehere. Recent vaccine introduction updates (since May 2015) include: · Pneumococcal conjugate vaccine (PCV) has been introduced in Eritrea, Guinea-Bissau, Lebanon, Lesotho, and Portugal. · Rotavirus vaccine has been introduced in Kiribati. · Inactivated polio vaccine (IPV) has been introduced in Benin, Bhutan, Cameroon, Central African Republic, Chad, Cote D'Ivoire, Guyana, Kiribati, TFYR Macedonia, Morocco, Niger, Pakistan, Papua New Guinea, Saint Vincent and the Grenadines, Sri Lanka, and Sudan.
Current and archived reports, as well as the PowerPoint slide deck with the latest report graphics, can also be found on the VIMS page of the IVAC website at:http://www.jhsph.edu/ivac/vims/ What is the VIMS Report? The VIMS report displays data and figures on the introduction status of Hib, pneumococcal, rotavirus, and inactivated polio vaccines both globally and in the 73 Gavi countries. The images and text in the report describe: · How many countries have introduced each vaccine or plan to in the future · National levels of vaccine coverage and access, globally and in Gavi countries · Vaccine introduction trends over time · Vaccine introduction status of each of the 194 countries, listed individually

INFORMATION NOTE: Vaccine vial monitor (VVM) assignments for different WHO-prequalified vaccines

WHO and UNICEF have jointly prepared an information bulletin which addresses varied implications of different types of vaccine vial monitors (VVMs), notably VVM category type 7 (VVM7) and VVM category type 14 (VVM14), on vaccines such as the Inactivated Polio Vaccine (IPV) and the fully-liquid Diphtheria-Tetanus- whole cell Pertussis-Hepatitis B-Haemophilus influenzae type b (DTP-HepB-Hib, commonly referred to as pentavalent). The note is directed to countries that are currently supplied by UNICEF Supply Division with these specific presentations of vaccine. The information is intended for WHO/UNICEF staff, as well as EPI managers or other partner agencies which support immunization programmes.

Both the english and french versions are attached here.

Immunization data from WHO

Moderator Publié dans :
Here are some of the latest immunization data available on the WHO website:

Global Immunization Data

Summary: Global immunization coverage in 2012

Immunization currently averts an estimated two to three million deaths every year in all age groups from diphtheria, tetanus, pertussis (whooping cough), and measles.

In 2012, an estimated 83% (111 million) of infants worldwide were vaccinated with three doses of diphtheria-tetanus-pertussis (DTP3) vaccine. Three regions ? the Americas, Europe and Western Pacific ? maintained over 90% DTP3 immunization coverage, the Western Pacific reaching 97%.

Number of countries reaching 80% or more immunization coverage with DTP3 vaccine in 2012: 165 countries compared to 164 in 2011.

Number of countries reaching over 90% or more immunization coverage with DTP3 vaccine in 2012: 131 countries compared to 128 in 2011.

Increasing uptake of new and underused vaccines
Hepatitis B vaccine for infants was introduced nationwide in 181 countries by the end of 2012. Global coverage with three doses of hepatitis B vaccine is estimated at 79% and is as high as 91% in the Western Pacific and the Americas. Coverage in the South-East Asia Region reached 72% in 2012 up from 56% in 2011.

Haemophilus influenzae type B (Hib) vaccine was introduced in 184 countries by the end of 2012 (including in parts of Belarus, India, Maldives and Nigeria), up from 177 countries in 2011. Global coverage with three doses of Hib vaccine is estimated at 45% in 2012, reaching 91% in the Americas, but only 11% and 14% in the South-East Asia Region and in the Western Pacific Region, respectively.

Rubella vaccine was introduced nationwide in 132 countries by the end of 2012, up from 85countries in 1996. There has been remarkable progress towards the elimination of rubella and congenital rubella syndrome in the Americas with a reduction of99.99% of confirmed cases between 1998 and 2012.

Mumps vaccine was introduced nationwide in 120 countries by the end of 2012.

Yellow fever vaccine was introduced in routine infant immunization programmes in 36 countries and territories out of the 48 at risk for yellow fever in Africa and the Americas.

Maternal and neonatal tetanus (MNT): One hundred and three countries provide Tetanus Toxoid-containing vaccine to prevent against maternal and neonatal tetanus (MNT). In these countries, the estimate for the protection of newborns at birth from tetanus that is derived from vaccination coverage
with at least two doses of Tetanus Toxoid vaccine or Tetanus-diphtheria Toxoid vaccine was estimated at 81% in 2012. As of December 2012, maternal and neonatal tetanus persist as a public health problems in 30 countries, mainly in Africa and Asia.

You can access more data here.

The WHO page: http://www.who.int/immunization/monitoring_surveillance/en/

Cocktails safe or not?

Hi All,

After several years of working in Immunization related activities to help others, I find myself on the other side of the fence, with a 2 month old baby, in Senegal, trying to get her shots. She was born in the US, and we opted not do the HEP B at birth and figured to start at 2 months. We went to a fancy pharmacy in Saly, where they only had DTaP + PCV + Hib + Polio as a cocktail and didn't know anything about RV and then Hep B as a standalone.

I had in the past heard concerns about such cocktails (which may be rumour), but then came across this article India Serves Up Costly Cocktail of Vaccines and wondered if the claims regarding adverse reactions and deaths are true.

If we want to avoid cocktails, is it possible to do so still? Would there be any benefit to dividing immunizations up so that DTP/Polio/Hep B are on one schedule, and PCV/Rota are on another, and a month out of phase (for example)? Is Hib really necessary?

I'm sorry to post a question of such a personal nature on Technet, but the amount of information online regarding child immunization is overwhelming and riddled with contradictions. WHO and CDC policy are one thing but also developed as blanket approaches to maximize the overall benefit to populations (no?). I have the ability to take as as many trips as needed to the pediatrician, and can afford to buy vaccines separately - should I?

Many thanks,

  • Page :
  • 1